This announcement is a separate document:
明治ホールディングス：新型コロナウイルス感染症に対するオミクロン株JN.1系統対応次世代mRNAワクチン「コスタイベ筋注用」の日本における一部変更承認取得に関するお知らせ
Meiji Holdings: Notice regarding approval for partial changes in Japan for the next-generation mRNA vaccine “Kosibebe muscle administration” compatible with the Omicron variant JN.1 lineage against the novel coronavirus infection
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated